Dr Yakisich received his M.D.
from University of Buenos Aires (1994) and his Ph.D.
in Neurology from the Karolinska Institute (2005). He received postdoctoral
training at the Health Science Center (Texas A&M
University, TX, USA).
He was appointed
Forskarassistent (Research Associate, Project Leader) at the Department of Clinical Neuroscience, Karolinska Institute
(Stockholm, Sweden) in 2008.
He also serves as reviewers of
several scientific journal and is Editor-In-Chief of
Drugs & Therapy
Dr. Yakisich's group has
developed new concepts and strategies for cancer treatment:
Regrowth concentration zero (RC0)
Pankiller drugs, Read the
Stemness Phenotype Model of
glioma biology. Read the article (PDF)
Two phases treatment (2FT)
to eliminate drug-surviving cells as strategy to prevent tumor relapse. Read
the article (PDF)
Publication List from PubMed